Empowering the next generation of clinicians through innovation and collaboration

At Castle Biosciences, we understand that the future of patient care lies in the hands of today’s residents and early-career clinicians. That’s why we’re committed to fostering collaboration, providing cutting-edge insights, and supporting professional growth at every step of your journey.

Leading the way in precision medicine

By partnering with the next generation of healthcare leaders, we’re equipping you with advanced diagnostic tools and personalized medicine solutions that empower better decision-making for your patients. Together, we can shape the future of precision medicine.

Partnering together for research opportunities

At Castle Biosciences, we believe in advancing precision medicine through collaborative research. By partnering together, we can push the boundaries of science and medicine to make a meaningful impact.

See how we have worked with your colleagues:

  • Practice update: Incorporating prognostic gene expression profile assays into the management of cutaneous melanoma: An expert consensus panel report

    Danny Zakria, MD, MBA, Nicholas Brownstone, MD, Brian Berman, MD, Roger Ceilley, MD, Gary Goldenberg, MD, Mark Lebwohl, MD, Graham Litchman, DO, Daniel Siegel, MD

  • SKIN: Incorporating prognostic gene expression profile assays into the management of cutaneous melanoma: An expert consensus panel report

    Danny Zakria, MD, MBA, Nicholas Brownstone, MD, Brian Berman, MD, Roger Ceilley, MD, Gary Goldenberg, MD, Mark Lebwohl, MD, Graham Litchman, DO, Daniel Siegel, MD

  • SKIN: The integrated 31-gene expression profile (i31-GEP) test for cutaneous melanoma outperforms a clinicopathologic-only nomogram at identifying patients who can forego sentinel lymph node biopsy 

    Danny Zakria, MD, MBA, Nicholas Brownstone, MD, Darrell S. Rigel, MD, MS

  • Journal of Drugs in Dermatology: Incorporating a prognostic gene expression profile test into  the management of cutaneous squamous cell carcinoma:  An expert consensus panel report 

    Danny Zakria MD MBA, Nicholas Brownstone MD, Brian Berman MD, Roger Ceilley MD, Terrence A. Cronin Jr. MD, James Q. Del Rosso DO, Laura K. Ferris MD PhD, Gary Goldenberg MD, Daniel Siegel MD

  • Journal of Drugs in Dermatology: Advances in technology for melanoma diagnosis  and prognosis: An expert consensus panel 

    Joshua Burshtein MD, Danny Zakria MD MBA, Milaan Shah MD, Brian Berman MD PhD, Seemal R. Desai MD, Aaron S. Farberg MD, Gary Goldenberg MD, Brad Glick DO MPH, Mark Nestor MD PhD, Keyvan Nouri MD MBA, Theodore Rosen MD, Mark Lebwohl MD, Darrell Rigel MD MS

  • AAD abstract: Impact of the integrated 31-gene expression profile (i31-GEP) test on identifying patients with T1-T2a cutaneous melanoma likely to experience disease progression 

    Danny Zakria, MD, MBA, Brian Martin, PhD, Nicholas Brownstone, MD

  • ASDP abstract: The 31-gene expression profile test (31-GEP) predicts risk of death in a large, unselected population of Medicare-eligible patients: a Surveillance, Epidemiology and End Results (SEER) collaboration

    Abel Jarell, MD, Harrison Nguyen, MD, MBA, MPH, Jung S. Byun, MD, MPH, Valentina I. Petkov, MD, Sonia K. Morgan-Linnell, PhD, Danny Zakria, MD, MBA, Michael Tassavor, MD

  • Maui Derm conference encore: The health economic impact of the 31-gene expression profile test for treatment and surveillance management plans in patients with cutaneous melanoma

    Danny Zakria, MD, MBA, Joshua Burshtein, MD, Milaan Shah, MD, Jennifer J. Siegel, PhD, Sonia K. Morgan-Linnell, PhD, Brian J. Martin, PhD, Robert W. Cook, PhD

  • EADO abstract: The health economic impact of the 31-gene expression profile test for treatment and surveillance management plans in patients with cutaneous melanoma

    Danny Zakria, MD, MBA, Joshua Burshtein, MD, Milaan Shah, MD, Jennifer J. Siegel, PhD, Sonia K. Morgan-Linnell, PhD, Brian J. Martin, PhD, Robert W. Cook, PhD

  • Winter Clinical abstract: The integrated 31-gene expression profile for sentinel lymph node biopsy (SLN) outperforms the MSKCC nomogram in predicting the risk of having a positive SLN in patients with cutaneous melanoma

    Danny Zakria, MD, Sonia K. Morgan-Linnell, Ph.D., Nicholas Brownstone, MD

Collaborate with us

Advancing education in dermatologic cancers

We are committed to supporting early-career clinicians through educational opportunities that empower you to deliver exceptional patient care. By connecting you with the latest advancements in precision diagnostics and personalized medicine, we aim to equip you with the knowledge and tools needed to make informed clinical decisions.

Learn with us

Building connections with early-career clinicians

At Castle Biosciences, we believe in the power of collaboration and connection. That’s why we’re proud to offer networking opportunities tailored for early-career clinicians. By engaging with peers, mentors, and industry experts, you’ll have the chance to exchange ideas, share experiences, and build lasting professional relationships.

Our events and forums are designed to foster meaningful dialogue and create a supportive community that helps you thrive in your career while driving innovation in patient care.

Resident Meet and Greet

Join us for an opportunity to network and meet with Program Directors from the 34 Breast Fellowship Programs and 34 CGSO Programs that participate.

Rising Derm Stars

A prestigious initiative that aims to honor and spotlight the top rising 20 talents in the dermatology field. The 20 selected participants are paired with a distinguished facutly mentor, offering an invaluable chance to glean insights directly from esteemed educators in dermatology. 

Join us at Fall Clinical 2025.

Learn more

Real World Dermatology for Residents

Real World Dermatology for Residents is designed to teach dermatology residents everything they really need to know when they begin their practice. This unique experience is the only one of its kind in the U.S.

Learn more

Project LEAD

An educational platform for early-career dermatologists that features webinars, videos, job boards, and more. LEAD offers mentorship on personal and professional development.

Join us at Fall Clinical 2025.

Learn more

Early Career Dermatology Initiative

A unique opportunity geared specifically for early career dermatologists in the first 10 years of practice, and beyond. The curriculum provides both clinical and practical information–everything you need to know as you build your practice post-residency.

Join us at Fall Clinical 2025.

Learn more

Board Immersion

Board Immersion is a 2-day virtual event with immersive lectures to prepare attendees for the most prominent board exam questions.

Learn more
Let's connect

Ready to be part of the future of dermatologic care?

Connect with a rep
Join our email list